[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Taichung Tzu Chi Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":122},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,40,69,98],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100647864","prehabilitation-for-upper-gastrointestinal-tract-cancer-surgery-100647864",false,"NCT07713888","Prehabilitation for Upper Gastrointestinal Tract Cancer Surgery","The Effects of Multimodal Prehabilitation on Post-operative Recovery in Patients Undergoing Surgery for Upper Gastrointestinal Tract Cancer in Taiwan","Inclusion Criteria:\n\n* aged ≥ 18 years\n* with a diagnosis of potentially resectable upper gastrointestinal tract cancer\n\nExclusion Criteria:\n\n* inability to give informed consent\n* non resectable disease\n* patients who declined surgery","ALL","18 Years",{"count":19,"type":20},40,"ESTIMATED","INTERVENTIONAL",[23],"NA","Patients receiving surgery of upper gastrointestinal tract are often elderly, frail, malnourished, with poor functional reserve. They are associated with poor post-operative outcomes.\n\nThis multimodal treatment is associated with considerable morbidity and decline of patients' functional capacity due to sarcopenia and malnutrition. The poor outcomes can lead to a prolonged delayed recovery, hospital stay, and disability. The post-operative morbidity, especially cardiopulmonary complications, remains substantial. Prehabilitation before surgery can improve the functional capacity of patients to better withstand the stress of surgery.\n\nIn this perspective, prehabilitation has gained increasing popularity as it consists of various interventions that aim to optimize patient's preoperative condition. The rehabilitation programmes varies considerably. To maximise the benefits that can be accrued in the pre-operative period, prehabilitation programmes should be multimodal, including exercise and nutritional support. Increasing the maximal aerobic capacity by training before surgery, improves patients' functional capacity and should allow patients to better withstand the postoperative stress response.\n\nPrehabilitation has been trialled in a range of surgical specialities, including colorectal, breast, hepatobiliary, bariatric, urological, thoracic, and orthopaedic surgery. In major abdominal surgery, multiple studies have indicated that prehabilitation improved preoperative functional capacity and postoperative outcomes. There is a large body of evidence for prehabilitation in patients undergoing intra-abdominal surgery, with studies reporting improvements in pre-operative cardiopulmonary fitness, and reductions in post-operative complications.\n\nThe data on prehabilitation after surgery for upper gastrointestinal tract are scarce and ambiguous and these studies often lacked a multimodal approach. The evidence of prehabilitation in Taiwan is scarce also. Surgery for upper gastrointestinal tract has a high morbidity and is associated with a prolonged recovery so there is significant potential to improve outcomes in this high-risk population. However, there are few studies of prehabilitation in surgery for upper gastrointestinal tract.\n\nHence, this study aimed to investigate the effect of a multimodal personalised, prehabilitation program on postoperative recovery and morbidity in patients undergoing surgery for upper gastrointestinal tract.",[26],"Surgery of Upper Gastrointestinal Tract Cancer","NOT_YET_RECRUITING","2026-07-15",{"date":30,"type":31},"2026-07-20","ACTUAL",{"date":33,"type":20},"2026-08-01",{"date":35,"type":20},"2027-08-31",{"name":37,"class":38},"Taichung Tzu Chi Hospital","OTHER",1,{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":4,"eligibilityCriteria":45,"healthyVolunteers":11,"sex":16,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":4,"studyType":21,"phases":50,"briefSummary":51,"conditions":52,"keywords":55,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":39},"100606633","effects-of-antrodia-cinnamomea-on-the-hepatoma-patients-after-transcatheter-hepatic-artery-chemoembolization-100606633","NCT07178093","Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery Chemoembolization","Inclusion Criteria:\n\n* Sign the informed consent form\n* Aged between 20 and 80\n* Child-Pugh score class A, B\n* Serum bilirubin level ≤ 1.5 times the upper limit of normal, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels ≤ 2 times the upper limit of normal\n\nExclusion Criteria:\n\n* Unwillingness to sign the informed consent form\n* Child-Pugh score class C\n* Patients with main portal vein thrombosis\n* Patients with diffuse liver tumors\n* Those who are allergic to the contrast medium\n* Those with abnormal coagulation function\n* Those with severe dysfunction of brain, heart and lung\n* Patients with severe renal dysfunction (except those receiving renal dialysis)\n* Unable to cooperate\n* Those with uncontrolled arrhythmia and unstable blood pressure\n* Some patients with abnormal thyroid function\n* Any other contraindications such as active gastrointestinal bleeding, refractory ascites, or severe portal hypertension\n* Pregnant or lactating women","20 Years","80 Years",{"count":49,"type":20},60,[23],"Effects of Antrodia cinnamomea on the hepatoma patients after Transcatheter hepatic artery chemoembolization",[53,54],"Hepatocellular Carcinoma","Transarterial Chemoembolization",[56,57,58,59],"hepatocellular carcinoma (HCC), viral hepatitis, Antrodia cinnamomea, post-TACE syndrome","hepatocellular carcinoma","antrodia cinnamomea","post-TACE syndrome","RECRUITING","2025-09-16",{"date":63,"type":31},"2025-09-17",{"date":65,"type":31},"2023-01-01",{"date":67,"type":20},"2025-12-31",{"name":37,"class":38},{"id":70,"slug":71,"hasResults":11,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":4,"eligibilityCriteria":74,"healthyVolunteers":11,"sex":75,"minAge":46,"maxAge":76,"enrollmentInfo":77,"targetDuration":4,"studyType":21,"phases":79,"briefSummary":80,"conditions":81,"keywords":84,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":39},"100572208","a-preliminary-study-on-the-efficacy-of-danggui-shaoyao-san-and-cuscuta-chinensis-in-patients-with-primary-dysmenorrhea-100572208","NCT06730282","A Preliminary Study on the Efficacy of Danggui Shaoyao San and Cuscuta Chinensis in Patients with Primary Dysmenorrhea","Inclusion Criteria:\n\n1. Female participants aged 20 to 45 years.\n2. Regular menstrual cycles (21 to 42 days).\n3. History of moderate to severe primary dysmenorrhea (Visual Analogue Scale (VAS) score \\> 3) persisting for at least three consecutive menstrual cycles.\n4. Able to understand and complete the study questionnaires (e.g., MSQ).\n5. Willing to comply with study protocols, including taking study medications and attending follow-up visits.\n\nExclusion Criteria:\n\n1. Secondary dysmenorrhea caused by conditions such as endometriosis, pelvic inflammatory disease, or uterine fibroids.\n2. Current use of an intrauterine contraceptive device (IUD).\n3. Irregular menstrual cycles.\n4. Pregnant, breastfeeding, or planning pregnancy within the study period.\n5. Use of anticoagulant medications (e.g., aspirin, warfarin, or heparin).\n6. Known allergies to any components of the study medications.\n7. Severe uncontrolled systemic diseases (e.g., neurological disorders, immunodeficiency, or bleeding disorders).\n8. Concurrent use of other herbal medicines or alternative treatments for premenstrual syndrome or dysmenorrhea.\n9. Participation in another clinical trial during the study period.\n\n   \\-","FEMALE","45 Years",{"count":78,"type":20},200,[23],"This study aims to evaluate the efficacy of two traditional Chinese medicine (TCM) formulas, Danggui Shaoyao San (DSS) and Cuscuta Chinensis (Tu Si Zi), in treating primary dysmenorrhea (PD). Primary dysmenorrhea, a common condition characterized by painful menstrual cramps, affects many women of reproductive age and significantly impacts their quality of life. Conventional treatments, such as NSAIDs and oral contraceptives, often have limited efficacy or side effects, underscoring the need for alternative therapeutic options.\n\nIn this randomized, double-blind study, participants will be divided into four groups: DSS, Tu Si Zi, a combination of DSS and Tu Si Zi, and a placebo group. The study will measure treatment outcomes using the Visual Analogue Scale (VAS) for pain and the Menstrual Symptom Questionnaire (MSQ), which captures physical and emotional symptoms. Additionally, TCM-based tools like pulse diagnosis and constitution questionnaires will be employed to explore personalized treatment strategies.\n\nThis research seeks to determine whether these TCM formulas can alleviate pain and improve other menstrual symptoms, potentially providing broader benefits than conventional painkillers. The findings aim to support evidence-based integration of TCM in managing dysmenorrhea and inform clinicians and patients about effective therapeutic choices.",[82,83],"Primary Dysmenorrhea (PD)","Traditional Chinese Medicine (TCM) Approaches",[85,86,87,88,89],"Primary Dysmenorrhea","Traditional Chinese Medicine (TCM)","Danggui Shaoyao San (DSS)","Cuscuta Chinensis (Tu Si Zi)","Herbal Medicine","2024-12-11",{"date":92,"type":31},"2024-12-12",{"date":94,"type":20},"2024-12-01",{"date":96,"type":20},"2026-06-30",{"name":37,"class":38},{"id":99,"slug":100,"hasResults":11,"nctId":101,"briefTitle":102,"officialTitle":103,"acronym":4,"eligibilityCriteria":104,"healthyVolunteers":105,"sex":16,"minAge":46,"maxAge":47,"enrollmentInfo":106,"targetDuration":4,"studyType":21,"phases":108,"briefSummary":109,"conditions":110,"keywords":112,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":114,"lastUpdatePostDateStruct":115,"startDateStruct":117,"completionDateStruct":119,"leadSponsor":121,"locationsCount":39},"100552027","the-efficacy-of-music-on-perioperative-pain-management-100552027","NCT06467747","The Efficacy of Music on Perioperative Pain Management","The Efficacy of Intraoperative Music Stimulation on Perioperative Pain Management","Inclusion Criteria:\n\n* Older than 20 years old and younger than 80 years old\n* male or female\n* Scheduled for minimally invasive surgery (laparoscopic cholecystectomy, appendectomy)\n* Ambulatory surgery\n* American Society of Anesthesiologists (ASA) physical status I\\~III\n\nExclusion Criteria:\n\n* Severe hearing impairment\n* Severe pulmonary or cardiovascular disease\n* Brain or central nervous system (CNS) disorder\n* Long-term systemic steroid or daily morphine treatment\n* Pregnant women\n* Emergency surgery\n* The absence of informed consent",true,{"count":107,"type":20},90,[23],"The goal of this clinical trial is to learn if intraoperative music stimulation works to alleviate perioperative pain in surgical patients undergoing general anesthesia. It will also learn about the possible mechanisms by how music affects pain.\n\nThe main questions it aims to answer are:\n\nDoes music lower the number of times participants need to use a rescue analgesic? What changes occur in electroencephalogram (EEG) and nociception monitors when participants listen to music? Researchers will compare music to mute or control (hear ambient sounds without earphones) to see if music works to alleviate perioperative pain.\n\nParticipants will listen music or mute or ambient sounds throughout the operation, and receive routine anesthesia care.",[111],"Perioperative Pain Management",[113],"Music therapy","2024-08-07",{"date":116,"type":31},"2024-08-09",{"date":118,"type":31},"2024-07-03",{"date":120,"type":20},"2025-05",{"name":37,"class":38},""]